Market Scenario The Acute Myeloid Leukemia Treatment Market outlook expected to reach $ 1.2 billion by the end of 2023, this market is projected to growing at a CAGR of Approximately 5.3 % during 2017-2023. Acute myeloid leukemia (AML) is a cancer of the myeloid blood cells, causing extreme and rapid growth of abnormal white blood cells of the bone marrow. The rapid buildup of...